Americas

Although it can sometimes be a challenge to get a cranky, wriggling toddler into a child car seat, those safety...

Children who have a lot of infections in the first 18 months of life may have an increased risk for...

a global biopharmaceutical company, announced today that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and...

Presents Pivotal Data for Omarigliptin, Merck’s Investigational Once-Weekly DPP-4 Inhibitor, and Additional Data from the TECOS CV Safety Trial, at...

Canada-based Valeant Pharmaceuticals International has completed the acquisition of US-based Salix Pharmaceuticals for around $11bn.   Under the deal, Valeant...

US-based Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement with Japanese firm Mitsubishi Tanabe Pharma to develop...

BioCryst Pharmaceuticals has received a $35m contract to continue developing BCX4430, a drug that has shown early signs of fighting...

US-based biotechnology firm Signum Dermalogix has out-licensed SIG990, a new anti-inflammatory compound, to Dermata Therapeutics for the development of a...

Cipher Pharmaceuticals Inc., a rapidly growing specialty pharmaceutical dermatology company, has licensed the Canadian distribution rights to CF101, a novel...